We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Next-Generation Models Launched for Sediment Urinalysis Testing

By LabMedica International staff writers
Posted on 05 Oct 2015
Print article
Image: The UF-5000 Fully Automated Analyzer of Formed Elements in Urine (Photo courtesy pf Sysmex Corporation).
Image: The UF-5000 Fully Automated Analyzer of Formed Elements in Urine (Photo courtesy pf Sysmex Corporation).
Urine sediment analysis is an important test used in diagnosing renal disease and urinary tract disorders and a new model for this analysis has just been launched.

Urine testing is divided into urine chemistry, a primary test employing urine test paper, and urine sediment analysis, secondary testing to provide a more detailed analysis of specimens that have been determined to be abnormal during urine chemistry.

Urine sediment analysis is an important test used in diagnosing renal disease and urinary tract disorders. Clinical laboratory technologists use microscopes to observe (microscope testing), classify and measure formed elements in the urine, including red blood cells, white blood cells and bacteria. The ability to perform automated quantitative analysis of formed elements in the urine by using the flow cytometry method was established almost 20 years ago.

Sysmex Corporation (Kobe, Japan) has launched its new products in the sediment urinalysis testing field, the UF-5000/4000/3000 fully automated analyzers of formed elements in urine. The instruments will be rolled out successively on a global scale, beginning with the Japanese market in September 2015. The new models employ blue lasers and other technologies to improve precision and fraction1 and can be used for testing urine and other bodily fluids.

The modular concept is employed to flexibly enable instruments to be added as the number of specimens grows. This concept also allows for future linkage with urine chemistry analyzers and for transport connections among multiple devices at large-scale facilities. Designed to optimize customer usability, the models employ the “Silent Design 3” concept and have simple operating panels. Some RFID4 cassette-type reagents are used to simplify reagent management and replacement.

To contribute to customer operating efficiency, the models are provided in combination with the Urinalysis Work Area Information Management System (U-WAM), which enables urinalysis departments to centrally manage test results. By continuing to provide valuable products in the urinalysis field going forward, Sysmex aims to establish a leading global position in this field of testing.

Related Links:

Sysmex Corporation


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.